BridgeBio Pharma
Price & Volume
Stats
See more52W Range | $21.62-$39.47 |
Market Cap | $6.9B |
Shares Short | 18M |
Financials
See moreRevenue (12 Mos) | $221.9M |
Revenue Growth (YoY) | 237.1% |
Gross Profit (12 Mos) | $221.9M |
Diluted EPS | -$2.88 |
News
See moreYahoo Finance • 3 days ago
BridgeBio Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Commercial Update
Yahoo Finance • 9 days ago
BridgeBio Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update on February 20, 2025
Yahoo Finance • 12 days ago
BEYONTTRA™ (acoramidis), the First Near Complete TTR Stabilizer (≥90%), Approved by the European Commission to Treat ATTR-CM
Yahoo Finance • 15 days ago
Why BridgeBio Pharma, Inc. (BBIO) Is Among the Best Healthcare Stocks To Buy According to Analysts
About
CEO | Dr. Neil Kumar Ph.D. |
CFO | Dr. Brian C. Stephenson C.F.A., Ph.D. |
Address | 3160 Porter Drive, Palo Alto, CA, United States, 94304 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 550 |
